FOX 13's Allie Corey sat down with the chief of surgical oncology at TGH Institute and professor of surgery at USF Health as ...
Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in ...
Novocure’s positive phase 3 results boost pancreatic cancer treatment prospects. Read why NVCR stock is worth watching with ...
Patients with locally advanced pancreatic cancer demonstrated a two-month difference in survival with tumor-treating fields ...
The therapy uses Tumor Treating Fields, or electric fields, to kill cancer cells while sparing most nearby healthy cells, ...
NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.
Researchers have identified genetic variants linked to pancreatic cancer in Brazilian patients, offering new insights for ...
The phase 3 PANOVA-3 trial, designed to evaluate concomitant treatment with tumor treating fields and chemotherapy, met its ...
There's no routine screening test for pancreatic cancer, and symptoms can be mistaken for common illnesses.
Novocure stock soars 49% as the late-stage study of TTFields therapy for treating pancreatic adenocarcinoma meets the primary ...
Dec 2 (Reuters) - Novocure (NVCR.O), opens new tab said on Monday its experimental therapy extended the lives of patients with a form of advanced pancreatic cancer when combined with chemotherapy ...
Oncosil Medical's investors have been promised a “catalyst rich” 2025 and 2026, including expected filings to the local TGA ...